12:00 AM
May 16, 2011
 |  BC Week In Review  |  Company News  |  Deals

Aegis Therapeutics, Albany Medical College deal

Aegis and the college partnered to create an oral formulation of the college's breast cancer candidate AFPep using Aegis' Intravail transmucosal...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >